Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Coeptis Therapeutics Inc.COEP · Entity 133305 | Director · CEO and President · 10% owner | November 16, 2021 | November 18, 2021 |
| Z Squared Inc.COEP · Entity 6495 | Director · CEO and President · 10% owner | February 11, 2026 | February 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Coeptis Therapeutics Inc.
Report date November 16, 2021 · Filed November 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,800,000 |
Reported balance
After 2021-11-16 transaction · row 1
1 source rowRow 1 · 2021-11-16 · Sale · Disposed 1,200,000 · Balance 1,800,000 F1: The sales reported in this Form 4 were effected by the reporting person in connection with a divorce settlement. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected by the reporting person in connection with a divorce settlement.
Z Squared Inc.
Report date February 11, 2026 · Filed February 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 330,192 |
Reported balance
After 2026-02-11 transaction · row 1
1 source rowRow 1 · 2026-02-11 · Exercise / conversion · Acquired 148,875 · Balance 330,192 F1: Represents the weighted average exercise price of shares purchased upon exercise of stock options. |
| Common StockSEC Table I · non-derivative | Direct | 330,192 |
Reported balance
After 2026-02-11 transaction · row 2
1 source rowRow 2 · 2026-02-11 · Grant · Acquired 51,250 · Balance 330,192 F2: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average exercise price of shares purchased upon exercise of stock options.
F2: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC | Z Squared Inc. COEP · Entity 6495 | GrantCommon Stock | 51,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-26-001029 · ownership.xml · nonDerivative · entry 2 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,192 F2 · price: Represents a grant of restricted stock issued in connection with an option exchange program where the Reporting Person surrendered underwater options in exchange for a grant of restricted stock. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 22:00 UTC | Z Squared Inc. COEP · Entity 6495 | Exercise / conversionCommon stock | 148,875 | $7.05 | $1,049,568.75 |
DisclosureSEC source: 0001683168-26-001029 · ownership.xml · nonDerivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents the weighted average exercise price of shares purchased upon exercise of stock options. Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 22:27 UTC | Z Squared Inc. COEP · Entity 6495 | GrantNon-Qualified Stock Options (right to buy) · Derivative | 28,875 | Not disclosed Strike: $10.56 | Not disclosed |
DisclosureSEC source: 0001683168-25-001391 · ownership.xml · derivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,125 Underlying: Common Stock · 28,875 shares Expires not disclosed F1 · security: On March 4, 2025, the reporting person received a grant of 28,875 non-qualified stock options, under the 2022 equity incentive plan. F2 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F2 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Capital Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, in equal quarterly installments over such period, with the final options vesting on 12/31/28. F4 · derivative.expiration_date: Expiration date is ten years from the day of grant. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:30 UTC | Z Squared Inc. COEP · Entity 6495 | PurchaseCommon Stock | 14,004 | $0.66 | $9,242.64 |
DisclosureSEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 3 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,782,615 F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 22:30 UTC | Z Squared Inc. COEP · Entity 6495 | PurchaseCommon Stock | 6,000 | $0.67 | $4,020.00 |
DisclosureSEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 2 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,768,611 F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 22:30 UTC | Z Squared Inc. COEP · Entity 6495 | PurchaseCommon Stock | 5,050 | $0.69 | $3,484.50 |
DisclosureSEC source: 0001683168-24-000159 · ownership.xml · nonDerivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,762,611 F1 · balance_after: Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days. Read SEC document |
| December 07, 2023 Filed Dec 11, 2023 21:01 UTC | Z Squared Inc. COEP · Entity 6495 | GiftCommon Stock | 700,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-008778 · ownership.xml · nonDerivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,757,561 F1 · acquired: The listed shares were transferred to an estate planning trust that has an independent trustee, for the benefit of the Reporting Person's children and for no consideration. The Reporting Person does not serve as trustee of this trust nor does he have or share investment control over the listed shares held by this trust. The Reporting Person disclaims beneficial ownership of the shares held by the trust, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the listed shares for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 15:59 UTC | Z Squared Inc. COEP · Entity 6495 | GrantIncentive Stock Options (right to buy) · Derivative | 250,000 | Not disclosed Strike: $1.76 | Not disclosed |
DisclosureSEC source: 0001683168-23-000432 · ownership.xml · derivative · entry 2 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires not disclosed F2 · security: On January 27, 2023, the reporting person received a grant of 250,000 incentive stock options, under the 2022 equity incentive plan. F6 · derivative.exercise_price: The exercise price is equal to 110% of the FMV of the shares on the day of grant. F6 · price: The exercise price is equal to 110% of the FMV of the shares on the day of grant. F4 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26. F8 · derivative.expiration_date: Expiration date is five years from the day of grant, as the reporting person is a 10% owner and the options are incentive stock options. F10 · balance_after: Following the exercise of options under both reported transactions, the reporting person will have a total of 625,000 derivative securities beneficially owned. Read SEC document |
| January 27, 2023 Filed Jan 31, 2023 15:59 UTC | Z Squared Inc. COEP · Entity 6495 | GrantNon-qualified Stock Options (right to buy) · Derivative | 375,000 | Not disclosed Strike: $1.60 | Not disclosed |
DisclosureSEC source: 0001683168-23-000432 · ownership.xml · derivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires not disclosed F1 · security: On January 27, 2023, the reporting person received a grant of 375,000 stock options, as non-qualified options, under the 2022 equity incentive plan. F5 · derivative.exercise_price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F5 · price: The exercise price is the FMV of the shares, which is equal to the Company's stock price on the Nasdaq Global Market on the day of grant. F3 · derivative.exercise_date: Options will vest over 4 years, with the first 25% vesting on 12/31/23, and the balance vesting in equal quarterly installments over the succeeding three years, with the final options vesting on 12/31/26. F7 · derivative.expiration_date: Expiration date is ten years from the day of grant F9 · balance_after: Following the exercise of options under both reported transactions, the reporting person will have a total of 625,000 derivative securities beneficially owned. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 14:00 UTC | Coeptis Therapeutics Inc. COEP · Entity 133305 | SaleCommon Stock | 1,200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-21-005808 · ownership.xml · nonDerivative · entry 1 Mehalick David · CIK 0001846623 · Director · CEO and President · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800,000 F1 · price: The sales reported in this Form 4 were effected by the reporting person in connection with a divorce settlement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.